Valuation Novo Nordisk A/S

Equities

Market Closed - Nasdaq Copenhagen Other stock markets 01:20:00 14/04/26 am AEST			5-day change	1st Jan Change
238.25 ^DKK	-1.00%		+0.57%	-26.75%

14/04	Lineage Cell Therapeutics, Inc. Announces Formation of Scientific Advisory Board and Executive Appointment	CI
13/04	SKAGEN Vekst slips 2.47 percent in March - new positions initiated in Easyjet, Elkem and Vestas	FW

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	1,674,992	2,118,803	3,112,331	2,772,285	1,445,242	1,057,020	-	-
Change	-	26.5%	46.89%	-10.93%	-47.87%	-26.86%	-	-
Enterprise Value (EV) ¹	1,684,152	2,121,013	3,109,107	2,848,764	1,549,238	1,167,086	1,160,187	1,146,525
Change	-	25.94%	46.59%	-8.37%	-45.62%	-24.67%	-0.59%	-1.18%
P/E ratio	35.4x	38.4x	37.5x	27.6x	14.1x	11.5x	11.2x	10.3x
PBR	24x	25.6x	29.4x	19.3x	-	4.81x	4.2x	3.76x
PEG	-	2.2x	0.7x	1.3x	7.98x	-1.19x	5.62x	1.16x
Capitalization / Revenue	11.9x	12x	13.4x	9.55x	4.68x	3.7x	3.53x	3.32x
EV / Revenue	12x	12x	13.4x	9.81x	5.01x	4.09x	3.87x	3.6x
EV / EBITDA	26x	25.8x	27.8x	19.3x	10.4x	8.59x	8.09x	7.46x
EV / EBIT	28.7x	28.4x	30.3x	22.2x	12.1x	10.1x	9.58x	8.85x
EV / FCF	57.4x	37x	45.5x	38.6x	26.3x	25.8x	16.4x	13.9x
FCF Yield	1.74%	2.7%	2.2%	2.59%	3.81%	3.88%	6.09%	7.2%
Dividend per Share ²	5.2	6.2	9.4	11.4	11.7	10.73	11.26	12.32
Rate of return	1.41%	1.32%	1.35%	1.83%	3.6%	4.5%	4.73%	5.17%
EPS ²	10.37	12.22	18.62	22.63	23.03	20.8	21.22	23.1
Distribution rate	50.1%	50.7%	50.5%	50.4%	50.8%	51.6%	53.1%	53.3%
Net sales ¹	140,800	176,954	232,261	290,403	309,064	285,655	299,624	318,065
EBITDA ¹	64,669	82,171	111,987	147,446	149,640	135,929	143,466	153,721
EBIT ¹	58,644	74,809	102,574	128,339	127,658	115,600	121,123	129,495
Net income ¹	47,757	55,525	83,683	100,988	102,434	92,237	95,403	102,465
Net Debt ¹	9,160	2,210	-3,224	76,479	103,996	110,066	103,167	89,504
Reference price ²	367.50	469.00	698.10	624.20	325.25	238.25	238.25	238.25
Nbr of stocks (in thousands)	4,557,801	4,517,704	4,458,288	4,441,340	4,443,479	4,436,602	-	-
Announcement Date	2/2/22	1/2/23	31/1/24	5/2/25	3/2/26	-	-	-

¹DKK in Million²DKK

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
NOVO NORDISK A/S	11.58x	4.13x	8.67x	4.46%	168B
ELI LILLY AND COMPANY	27.6x	10.48x	21x	0.71%	841B
JOHNSON & JOHNSON	25.27x	5.88x	15.98x	2.22%	574B
ABBVIE INC.	23.1x	6.26x	12.64x	3.33%	368B
ASTRAZENECA PLC	25.82x	5.33x	14.9x	1.62%	318B
MERCK & CO., INC.	28.22x	5.02x	15.65x	2.78%	300B
NOVARTIS AG	21.36x	5.74x	13.88x	2.86%	295B
AMGEN INC.	23.42x	6.07x	10.8x	2.86%	189B
GILEAD SCIENCES, INC.	19.15x	5.87x	10.62x	2.34%	173B
Average	22.84x	6.09x	13.79x	2.57%	358.36B
Weighted average by Cap.	24.45x	6.89x	15.61x	2.16%